loadpatents
Patent applications and USPTO patent grants for Chari; Ravi V.J..The latest application filed is for "camptothecin derivatives".
Patent | Date |
---|---|
Camptothecin Derivatives App 20220133711 - Chari; Ravi V.J. ;   et al. | 2022-05-05 |
Camptothecin derivatives Grant 11,229,639 - Chari , et al. January 25, 2 | 2022-01-25 |
Conjugates Comprising Cell-binding Agents And Cytotoxic Agents App 20210299271 - Fishkin; Nathan Elliott ;   et al. | 2021-09-30 |
Cytotoxic benzodiazepine derivatives Grant 11,116,845 - Chari , et al. September 14, 2 | 2021-09-14 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates App 20210261683 - CHARI; Ravi V.J. ;   et al. | 2021-08-26 |
Novel Benzodiazepine Derivatives App 20210238301 - Li; Wei ;   et al. | 2021-08-05 |
Cross-linkers and their uses Grant 11,046,762 - Chari , et al. June 29, 2 | 2021-06-29 |
Conjugates comprising cell-binding agents and cytotoxic agents Grant 10,988,531 - Fishkin , et al. April 27, 2 | 2021-04-27 |
Camptothecin Derivatives App 20210077482 - Chari; Ravi V.J. ;   et al. | 2021-03-18 |
Benzodiazepine derivatives Grant 10,947,315 - Li , et al. March 16, 2 | 2021-03-16 |
Cytotoxic Benzodiazepine Derivatives App 20200405870 - Chari; Ravi V.J. ;   et al. | 2020-12-31 |
Benzodiazepine Derivatives App 20200397914 - Miller; Michael Louis ;   et al. | 2020-12-24 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said Grant 10,844,135 - Chari , et al. November 24, 2 | 2020-11-24 |
Cytotoxic benzodiazepine derivatives Grant 10,722,588 - Chari , et al. | 2020-07-28 |
Cross-linkers And Their Uses App 20200148764 - Chari; Ravi V.J. ;   et al. | 2020-05-14 |
Cytotoxic benzodiazepine derivatives Grant 10,570,212 - Li , et al. Feb | 2020-02-25 |
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20200048362 - Blattler; Walter ;   et al. | 2020-02-13 |
Cross-linkers and their uses Grant 10,494,431 - Chari , et al. De | 2019-12-03 |
Novel Benzodiazepine Derivatives App 20190276552 - Li; Wei ;   et al. | 2019-09-12 |
Cytotoxic Benzodiazepine Derivatives App 20190269786 - Chari; Ravi V.J. ;   et al. | 2019-09-05 |
Cytotoxic Benzodiazepine Derivatives App 20190263924 - Li; Wei ;   et al. | 2019-08-29 |
Cytotoxic benzodiazepine derivatives Grant 10,238,751 - Chari , et al. | 2019-03-26 |
Methods for preparing antibody-drug conjugates Grant 10,233,257 - Kellogg , et al. | 2019-03-19 |
Benzodiazepines And Conjugates Thereof App 20190070305 - Chari; Ravi V.J. ;   et al. | 2019-03-07 |
Benzodiazepine derivatives Grant 10,208,127 - Li , et al. Feb | 2019-02-19 |
Gcc-targeted Antibody-drug Conjugates App 20190038762 - VEIBY; Ole Petter ;   et al. | 2019-02-07 |
Cytotoxic benzodiazepine derivatives Grant 10,179,818 - Li , et al. Ja | 2019-01-15 |
Novel Benzodiazepine Derivatives App 20180355055 - Li; Wei ;   et al. | 2018-12-13 |
Cross-linkers And Their Uses App 20180291100 - Chari; Ravi V.J. ;   et al. | 2018-10-11 |
Benzodiazepines and conjugates thereof Grant 10,046,063 - Chari , et al. August 14, 2 | 2018-08-14 |
Cytotoxic benzodiazepine derivatives Grant 9,974,867 - Chari , et al. May 22, 2 | 2018-05-22 |
Novel Benzodiazepine Derivatives App 20180079823 - Li; Wei ;   et al. | 2018-03-22 |
Conjugation Methods App 20180079828 - Kellogg; Brenda A. ;   et al. | 2018-03-22 |
Cytotoxic Agents Comprising New Maytansinoids (dm4) App 20180043013 - Chari; Ravi V.J. ;   et al. | 2018-02-15 |
Cytotoxic Benzodiazepine Derivatives App 20180002440 - Li; Wei ;   et al. | 2018-01-04 |
Cytotoxic benzodiazepine derivatives Grant 9,840,564 - Li , et al. December 12, 2 | 2017-12-12 |
Cytotoxic Benzodiazepine Derivatives App 20170340748 - Chari; Ravi V.J. ;   et al. | 2017-11-30 |
Cytotoxic Benzodiazepine Derivatives App 20170340749 - Chari; Ravi V.J. ;   et al. | 2017-11-30 |
Benzodiazepines And Conjugates Thereof App 20170274091 - Chari; Ravi V.J. ;   et al. | 2017-09-28 |
Conjugation methods Grant 9,771,432 - Kellogg , et al. September 26, 2 | 2017-09-26 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates App 20170226220 - CHARI; Ravi V.J. ;   et al. | 2017-08-10 |
Novel Benzodiazepine Derivatives App 20170183419 - Li; Wei ;   et al. | 2017-06-29 |
Cross-linkers And Their Uses App 20170157264 - Chari; Ravi V.J. ;   et al. | 2017-06-08 |
Cytotoxic benzodiazepine derivatives Grant 9,669,102 - Chari , et al. June 6, 2 | 2017-06-06 |
Methods Of Treatment Using Anti-erbb Antibody Maytansinoid Conjugates App 20170106097 - BLATTLER; Walter ;   et al. | 2017-04-20 |
Cytotoxic Benzodiazepine Derivatives App 20170044266 - Li; Wei ;   et al. | 2017-02-16 |
Benzodiazepines and conjugates thereof Grant 9,555,125 - Chari , et al. January 31, 2 | 2017-01-31 |
Benzodiazepine derivatives Grant 9,550,787 - Li , et al. January 24, 2 | 2017-01-24 |
Conjugation Methods App 20170002096 - KELLOGG; Brenda A. ;   et al. | 2017-01-05 |
Cytotoxic benzodiazepine derivatives and methods of preparation Grant 9,534,000 - Chari January 3, 2 | 2017-01-03 |
Cytotoxic Benzodiazepine Derivatives App 20160367698 - Chari; Ravi V.J. ;   et al. | 2016-12-22 |
Cross-linkers and their uses Grant 9,498,541 - Chari , et al. November 22, 2 | 2016-11-22 |
Cytotoxic benzodiazepine derivatives Grant 9,434,748 - Li , et al. September 6, 2 | 2016-09-06 |
Novel Benzodiazepine Derivatives App 20160222013 - Li; Wei ;   et al. | 2016-08-04 |
Cytotoxic benzodiazepine derivatives Grant 9,381,256 - Chari , et al. July 5, 2 | 2016-07-05 |
Conjugation methods Grant 9,376,500 - Kellogg , et al. June 28, 2 | 2016-06-28 |
Potent Conjugates And Hydrophilic Linkers App 20160114052 - Singh; Rajeeva ;   et al. | 2016-04-28 |
Cytotoxic Benzodiazepine Derivatives App 20160108129 - Li; Wei ;   et al. | 2016-04-21 |
Cytotoxic Benzodiazepine Derivatives App 20160106863 - Chari; Ravi V.J. ;   et al. | 2016-04-21 |
Conjugates Comprising Cell-binding Agents And Cytotoxic Agents App 20160095938 - Fishkin; Nathan Elliott ;   et al. | 2016-04-07 |
Cytotoxic Benzodiazepine Derivatives App 20160082114 - Chari; Ravi V.J. ;   et al. | 2016-03-24 |
Cytotoxic Agents Comprising New Ansamitocin Derivatives App 20160058882 - Chari; Ravi V.J. ;   et al. | 2016-03-03 |
Benzodiazepine derivatives Grant 9,265,841 - Li , et al. February 23, 2 | 2016-02-23 |
Cross-linkers And Their Uses App 20150352223 - Chari; Ravi V.J. ;   et al. | 2015-12-10 |
Cytotoxic Benzodiazepine Derivatives App 20150315193 - Li; Wei ;   et al. | 2015-11-05 |
Cytotoxic benzodiazepine derivatives Grant 9,169,272 - Li , et al. October 27, 2 | 2015-10-27 |
Potent conjugates and hydrophilic linkers Grant 9,150,649 - Singh , et al. October 6, 2 | 2015-10-06 |
Benzodiazepines And Conjugates Thereof App 20150209444 - Chari; Ravi V.J. ;   et al. | 2015-07-30 |
Cytotoxic agents comprising new ansamitocin derivatives Grant 9,090,629 - Chari , et al. July 28, 2 | 2015-07-28 |
Cross-linkers and their uses Grant 9,061,995 - Chari , et al. June 23, 2 | 2015-06-23 |
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20150110816 - BLATTLER; Walter ;   et al. | 2015-04-23 |
Cytotoxic Benzodiazepine Derivatives App 20150099874 - Li; Wei ;   et al. | 2015-04-09 |
Cytotoxic Agents Comprising New Maytansinoids (dm4) App 20150071949 - Chari; Ravi V.J. ;   et al. | 2015-03-12 |
Novel Benzodiazepine Derivatives App 20150030616 - Li; Wei ;   et al. | 2015-01-29 |
Cytotoxic benzodiazepine derivatives Grant 8,889,669 - Li , et al. November 18, 2 | 2014-11-18 |
Cytotoxic agents comprising new maytansinoids Grant 8,841,425 - Chari , et al. September 23, 2 | 2014-09-23 |
Benzodiazepine derivatives Grant 8,809,320 - Li , et al. August 19, 2 | 2014-08-19 |
Benzodiazepine derivatives Grant 8,802,667 - Li , et al. August 12, 2 | 2014-08-12 |
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20140212411 - BLATTLER; Walter ;   et al. | 2014-07-31 |
Cytotoxic benzodiazepine derivatives Grant 8,765,740 - Li , et al. July 1, 2 | 2014-07-01 |
Conjugation Methods App 20140179906 - KELLOGG; Brenda A. ;   et al. | 2014-06-26 |
Cross-linkers And Their Uses App 20140178416 - Chari; Ravi V.J. ;   et al. | 2014-06-26 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates App 20140154804 - CHARI; Ravi V.J. ;   et al. | 2014-06-05 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Grant 8,685,920 - Chari , et al. April 1, 2 | 2014-04-01 |
Cytotoxic Benzodiazepine Derivatives And Methods Of Preparation App 20140088089 - Chari; Ravi V.J. | 2014-03-27 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents Grant RE44,704 - Chari , et al. January 14, 2 | 2014-01-14 |
Methods for preparation of antibody-maytansinoid conjugates Grant 8,624,003 - Kellogg , et al. January 7, 2 | 2014-01-07 |
Cross-linkers and their uses Grant 8,613,930 - Chari , et al. December 24, 2 | 2013-12-24 |
Cytotoxic Agents Comprising New Ansamitocin Derivatives App 20130323268 - Chari; Ravi V.J. ;   et al. | 2013-12-05 |
Cytotoxic Benzodiazepine Derivatives App 20130302359 - Li; Wei ;   et al. | 2013-11-14 |
Novel Benzodiazepine Derivatives App 20130302357 - Li; Wei ;   et al. | 2013-11-14 |
Novel Benzodiazepine Derivatives App 20130266596 - Li; Wei ;   et al. | 2013-10-10 |
Cytotoxic agents comprising new maytansinoids Grant 8,435,528 - Chari , et al. May 7, 2 | 2013-05-07 |
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20130108620 - BLATTLER; Walter ;   et al. | 2013-05-02 |
Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use Grant 8,404,678 - Bouchard , et al. March 26, 2 | 2013-03-26 |
Elimination of heterogeneous or mixed cell population in tumors Grant 8,388,960 - Goldmakher , et al. March 5, 2 | 2013-03-05 |
Cross-linkers And Their Uses App 20130011419 - Chari; Ravi V.J. ;   et al. | 2013-01-10 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents Grant RE43,899 - Blattler , et al. January 1, 2 | 2013-01-01 |
Methods of treatment using anti-ERBB antibody-maytansinoid conjugates Grant 8,337,856 - Blattler , et al. December 25, 2 | 2012-12-25 |
Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates App 20120282282 - Lutz; Robert J. ;   et al. | 2012-11-08 |
Cytotoxic Benzodiazepine Derivatives App 20120244171 - Li; Wei ;   et al. | 2012-09-27 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates App 20120226025 - CHARI; Ravi V.J. ;   et al. | 2012-09-06 |
Potent Conjugates And Hydrophilic Linkers App 20120226026 - SINGH; Rajeeva ;   et al. | 2012-09-06 |
Cross-linkers and their uses Grant 8,236,319 - Chari , et al. August 7, 2 | 2012-08-07 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Grant 8,198,417 - Steeves , et al. June 12, 2 | 2012-06-12 |
Cytotoxic agents comprising new tomaymycin derivatives Grant 8,163,736 - Gauzy , et al. April 24, 2 | 2012-04-24 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Grant 8,163,888 - Steeves , et al. April 24, 2 | 2012-04-24 |
Elimination of heterogeneous or mixed cell population in tumors Grant 8,137,669 - Goldmakher , et al. March 20, 2 | 2012-03-20 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates Grant 8,088,387 - Steeves , et al. January 3, 2 | 2012-01-03 |
Elimination Of Heterogeneous Or Mixed Cell Population In Tumors App 20110319612 - GOLDMAKHER; Viktor S. ;   et al. | 2011-12-29 |
Prodrugs Of Cc-1065 Analogs App 20110280890 - ZHAO; Robert ;   et al. | 2011-11-17 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates App 20110281856 - CHARI; Ravi V. J. ;   et al. | 2011-11-17 |
Prodrugs of CC-A1065 analogs Grant 8,012,978 - Zhao , et al. September 6, 2 | 2011-09-06 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Grant 7,989,598 - Steeves , et al. August 2, 2 | 2011-08-02 |
Cytotoxic Agents Comprising New Maytansinoids App 20110158991 - CHARI; Ravi V.J. ;   et al. | 2011-06-30 |
Prodrugs of CC-1065 analogs Grant 7,906,545 - Zhao , et al. March 15, 2 | 2011-03-15 |
Prodrugs Of Cc-1065 Analogs App 20110008373 - ZHAO; Robert Yongxin ;   et al. | 2011-01-13 |
Leptomycin Derivatives App 20110002947 - BOUCHARD; Herve ;   et al. | 2011-01-06 |
Conjugation Methods App 20110003969 - Kellogg; Brenda A. ;   et al. | 2011-01-06 |
Cytotoxic Agents Comprising New Tomaymycin Derivatives And Their Therapeutic Use App 20100316656 - Bouchard; Herve ;   et al. | 2010-12-16 |
Cytotoxic agents comprising new maytansinoids Grant 7,851,432 - Chari , et al. December 14, 2 | 2010-12-14 |
Leptomycin derivatives Grant 7,816,543 - Bouchard , et al. October 19, 2 | 2010-10-19 |
Potent Conjugates And Hydrophilic Linkers App 20100129314 - Singh; Rajeeva ;   et al. | 2010-05-27 |
Potent Cell-binding Agent Drug Conjugates App 20100092495 - CHARI; Ravi V. J. | 2010-04-15 |
Cytotoxic agents comprising new taxanes Grant 7,667,054 - Miller , et al. February 23, 2 | 2010-02-23 |
Prodrugs of CC-1065 analogs Grant 7,655,661 - Zhao , et al. February 2, 2 | 2010-02-02 |
Prodrugs of CC-1065 analogs Grant 7,655,660 - Zhao , et al. February 2, 2 | 2010-02-02 |
Prodrugs Of Cc-1065 Analogs App 20090281158 - ZHAO; ROBERT YONGXIN ;   et al. | 2009-11-12 |
Cross-linkers And Their Uses App 20090274713 - CHARI; Ravi V. J. ;   et al. | 2009-11-05 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents Grant 7,601,354 - Chari October 13, 2 | 2009-10-13 |
Cytotoxic agents comprising new C-2 modified taxanes Grant 7,598,290 - Miller , et al. October 6, 2 | 2009-10-06 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 7,585,857 - Chari , et al. September 8, 2 | 2009-09-08 |
Leptomycin Derivatives App 20090182038 - Bouchard; Herve ;   et al. | 2009-07-16 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 7,550,609 - Chari , et al. June 23, 2 | 2009-06-23 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 7,528,130 - Chari , et al. May 5, 2 | 2009-05-05 |
Elimination Of Heterogeneous Or Mixed Cell Population In Tumors App 20090076263 - Goldmakher; Viktor S. ;   et al. | 2009-03-19 |
Cytotoxic agents containing novel potent taxanes and their therapeutic use Grant 7,495,114 - Baloglu , et al. February 24, 2 | 2009-02-24 |
Cytotoxic Agents Comprising New Tomaymycin Derivatives App 20090036431 - GAUZY; Laurence ;   et al. | 2009-02-05 |
Prodrugs Of Cc-a1065 Analogs App 20090028821 - Zhao; Robert ;   et al. | 2009-01-29 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 7,476,669 - Chari , et al. January 13, 2 | 2009-01-13 |
Cytotoxic agents comprising new maytansinoids Grant 7,473,796 - Chari , et al. January 6, 2 | 2009-01-06 |
Prodrugs Of Cc-1065 Analogs App 20080260685 - ZHAO; Robert Yongxin ;   et al. | 2008-10-23 |
Cytotoxic agents containing novel potent taxanes and their therapeutic use Grant 7,414,073 - Baloglu , et al. August 19, 2 | 2008-08-19 |
Process for preparation of maytansinol Grant 7,411,063 - Widdison , et al. August 12, 2 | 2008-08-12 |
Cytotoxic agents containing novel potent taxanes and their therapeutic use Grant 7,390,898 - Baloglu , et al. June 24, 2 | 2008-06-24 |
Prodrugs of CC-1065 analogs Grant 7,388,026 - Zhao , et al. June 17, 2 | 2008-06-17 |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents Grant 7,368,565 - Chari , et al. May 6, 2 | 2008-05-06 |
CC-1065 analog synthesis Grant 7,329,760 - Zhao , et al. February 12, 2 | 2008-02-12 |
Cytotoxic Agents Comprising Taxanes And Their Therapeutic Use App 20080027130 - CHARI; Ravi V.J. ;   et al. | 2008-01-31 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents Grant 7,303,749 - Chari December 4, 2 | 2007-12-04 |
Method for the preparation of maytansinoid esters Grant 7,301,019 - Widdison , et al. November 27, 2 | 2007-11-27 |
Cytotoxic Agents Comprising New Maytansinoids App 20070269447 - Chari; Ravi V. J. ;   et al. | 2007-11-22 |
Cytotoxic Agents Comprising New Maytansinoids App 20070270585 - Chari; Ravi V. J. ;   et al. | 2007-11-22 |
Cytotoxic Agents Comprising New C-2 Modified Taxanes App 20070270482 - Miller; Michael L. ;   et al. | 2007-11-22 |
Cytotoxic Agents Comprising New Maytansinoids App 20070264266 - Chari; Ravi V. J. ;   et al. | 2007-11-15 |
Cytotoxic agents comprising new maytansinoids Grant 7,276,497 - Chari , et al. October 2, 2 | 2007-10-02 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 7,276,499 - Chari , et al. October 2, 2 | 2007-10-02 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20070197775 - Chari; Ravi V.J. ;   et al. | 2007-08-23 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20070196332 - Chari; Ravi V.J. ;   et al. | 2007-08-23 |
Prodrugs of CC-1065 analogs App 20070135346 - Zhao; Robert Yongxin ;   et al. | 2007-06-14 |
Process for preparation of maytansinol App 20070112188 - Widdison; Wayne C. ;   et al. | 2007-05-17 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 7,217,819 - Chari , et al. May 15, 2 | 2007-05-15 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents App 20060233811 - Chari; Ravi V.J. | 2006-10-19 |
Elimination of heterogeneous or mixed cell population in tumors App 20060233814 - Goldmakher; Viktor S. ;   et al. | 2006-10-19 |
Cytotoxic agents comprising new taxanes App 20060178427 - Miller; Michael L. ;   et al. | 2006-08-10 |
Method for the preparation of maytansinoid esters App 20060167245 - Widdison; Wayne C. ;   et al. | 2006-07-27 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20060122259 - Chari; Ravi V. J. ;   et al. | 2006-06-08 |
Prodrugs of CC-1065 analogs Grant 7,049,316 - Zhao , et al. May 23, 2 | 2006-05-23 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20060106090 - Chari; Ravi V.J. ;   et al. | 2006-05-18 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 7,008,942 - Chari , et al. March 7, 2 | 2006-03-07 |
Prodrugs of CC-1065 analogs App 20060009462 - Yongxin; Robert ;   et al. | 2006-01-12 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20050272729 - Chari, Ravi V.J. ;   et al. | 2005-12-08 |
Cytotoxic agents containing novel potent taxanes and their therapeutic use App 20050085513 - Baloglu, Erkan ;   et al. | 2005-04-21 |
Cytotoxic agents containing novel potent taxanes and their therapeutic use App 20050026997 - Baloglu, Erkan ;   et al. | 2005-02-03 |
Cytotoxic agents comprising new maytansinoids App 20040235840 - Chari, Ravi V.J. ;   et al. | 2004-11-25 |
Prodrugs of CC-1065 analogs Grant 6,756,397 - Zhao , et al. June 29, 2 | 2004-06-29 |
Prodrugs of CC-1065 analogs App 20040109867 - Yongxin, Robert ;   et al. | 2004-06-10 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20040087649 - Chari, Ravi V.J. ;   et al. | 2004-05-06 |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same Grant 6,716,821 - Zhao , et al. April 6, 2 | 2004-04-06 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 6,706,708 - Chari , et al. March 16, 2 | 2004-03-16 |
Cytotoxic agents containing novel potent taxanes and their therapeutic use App 20040024049 - Baloglu, Erkan ;   et al. | 2004-02-05 |
Cytotoxic Agents Bearing A Reactive Polyethylene Glycol Moiety, Cytotoxic Conjugates Comprising Polyethylene Glycol Linking Groups, And Methods Of Making And Using The Same App 20040001838 - Zhao, Robert Yongxin ;   et al. | 2004-01-01 |
Prodrugs of CC-1065 analogs App 20030199519 - Zhao, Robert Yongxin ;   et al. | 2003-10-23 |
CC-1065 analog synthesis App 20030195365 - Zhao, Robert Yongxin ;   et al. | 2003-10-16 |
Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use Grant 6,630,579 - Chari , et al. October 7, 2 | 2003-10-07 |
Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use Grant 6,596,757 - Chari , et al. July 22, 2 | 2003-07-22 |
CC-1065 analog synthesis Grant 6,586,618 - Zhao , et al. July 1, 2 | 2003-07-01 |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents App 20030055226 - Chari, Ravi V. J. ;   et al. | 2003-03-20 |
CC-1065 analog synthesis Grant 6,534,660 - Yongxin , et al. March 18, 2 | 2003-03-18 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20030004210 - Chari, Ravi V.J. ;   et al. | 2003-01-02 |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents Grant 6,441,163 - Chari , et al. August 27, 2 | 2002-08-27 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 6,436,931 - Chari , et al. August 20, 2 | 2002-08-20 |
Cytotoxic Agents Comprising Taxanes And Their Therapeutic Use App 20020086897 - Chari, Ravi V. J. ;   et al. | 2002-07-04 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 6,372,738 - Chari , et al. April 16, 2 | 2002-04-16 |
Cytotoxic agents comprising taxanes and their therapeutic use App 20020013485 - Chari, Ravi V.J. ;   et al. | 2002-01-31 |
Cytotoxic agents comprising taxanes and their therapeutic use Grant 6,340,701 - Chari , et al. January 22, 2 | 2002-01-22 |
Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use App 20010036923 - Chari, Ravi V.J. ;   et al. | 2001-11-01 |
Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs Grant 5,846,545 - Chari , et al. December 8, 1 | 1998-12-08 |
Cyclopropylbenzindole-containing cytotoxic drugs Grant 5,585,499 - Chari , et al. December 17, 1 | 1996-12-17 |
Cell binding agent conjugates of analogues and derivatives of CC-1065 Grant 5,475,092 - Chari , et al. December 12, 1 | 1995-12-12 |
Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity Grant 5,395,924 - Blattler , et al. March 7, 1 | 1995-03-07 |
Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicity Grant 5,239,062 - Blattler , et al. August 24, 1 | 1993-08-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.